Innova Captab Limited Share Price & Analysis
₹867.5▼ -0.58%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹867.5
-0.58%
Open
₹—
High
₹889
Low
₹857.05
Close
₹867.5
52W High
₹1,021
52W Low
₹608
Volume
24K
Lot Size
1
Sector
Healthcare
Market Cap
₹5K Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
35
Sector P/E
48.9
P/B
4.54
EPS
₹23.14
ROE
13.8%
ROCE
15%
D/E Ratio
0.32
Div Yield
0.23%
Book Value
₹191
+
Strengths
- ✓Efficient capital deployment (ROCE 15%)
- ✓Attractively valued vs sector (P/E 35x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
INNOVACAP · as of Mar 2026
Promoters50.90%
FII0.08%▼0.15
DII20.17%▲0.50
Public28.86%▼0.34
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% |
| FII | 1.19% | 1.01% | 0.74% | 0.35% | 0.23% | 0.08% |
| DII | 21.24% | 20.61% | 19.96% | 19.77% | 19.67% | 20.17% |
| Public | 26.67% | 27.48% | 28.41% | 29.00% | 29.20% | 28.86% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
Results6 May 2026
Interim Dividend - Rs 2 Per Share
Dividend29 Jan 2026
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹450 Cr ▲18.4% | ₹380 Cr ▲8.0% | ₹352 Cr ▲11.7% | ₹315 Cr ▼0.3% | ₹316 Cr ▼0.6% | ₹318 Cr ▲8.2% | ₹294 Cr ▲11.8% | ₹263 Cr |
| Op. Profit | ₹69 Cr ▲32.7% | ₹52 Cr ▲0.0% | ₹52 Cr ▲8.3% | ₹48 Cr ▲2.1% | ₹47 Cr ▼6.0% | ₹50 Cr ▲19.0% | ₹42 Cr ▲10.5% | ₹38 Cr |
| OPM | 15.0% ▲7.1% | 14.0% ▼6.7% | 15.0% ▲0.0% | 15.0% ▲0.0% | 15.0% ▼6.3% | 16.0% ▲14.3% | 14.0% ▲0.0% | 14.0% |
| Net Profit | ₹42 Cr ▲40.0% | ₹30 Cr ▼3.2% | ₹31 Cr ▲3.3% | ₹30 Cr ▼11.8% | ₹34 Cr ▼2.9% | ₹35 Cr ▲20.7% | ₹29 Cr ▲0.0% | ₹29 Cr |
| EPS (₹) | 7.37 ▲42.3% | 5.18 ▼4.4% | 5.42 ▲4.8% | 5.17 ▼13.5% | 5.98 ▼2.3% | 6.12 ▲18.8% | 5.15 ▲2.6% | 5.02 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.6K Cr ▲31.0% | ₹1.2K Cr ▲15.1% | ₹1.1K Cr ▲16.7% | ₹926 Cr ▲15.6% | ₹801 Cr ▲94.9% | ₹411 Cr ▲10.2% | ₹373 Cr ▲4.8% | ₹356 Cr |
| Expenses | ₹1.4K Cr ▲31.2% | ₹1.1K Cr ▲14.0% | ₹927 Cr ▲14.0% | ₹813 Cr ▲15.5% | ₹704 Cr ▲97.8% | ₹356 Cr ▲10.6% | ₹322 Cr ▲2.2% | ₹315 Cr |
| Op. Profit | ₹243 Cr ▲30.6% | ₹186 Cr ▲20.8% | ₹154 Cr ▲35.1% | ₹114 Cr ▲18.8% | ₹96 Cr ▲77.8% | ₹54 Cr ▲5.9% | ₹51 Cr ▲24.4% | ₹41 Cr |
| OPM | 15.0% ▲0.0% | 15.0% ▲7.1% | 14.0% ▲16.7% | 12.0% ▲0.0% | 12.0% ▼7.7% | 13.0% ▼7.1% | 14.0% ▲27.3% | 11.0% |
| Other Income | ₹7 Cr ▼41.7% | ₹12 Cr ▲0.0% | ₹12 Cr ▲33.3% | ₹9 Cr ▲200.0% | ₹3 Cr ▲200.0% | ₹1 Cr ▲0.0% | ₹1 Cr | ₹0 Cr |
| Interest | ₹17 Cr ▲750.0% | ₹2 Cr ▼90.5% | ₹21 Cr ▲5.0% | ₹20 Cr ▲233.3% | ₹6 Cr ▲50.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▼16.7% | ₹6 Cr |
| Depreciation | ₹45 Cr ▲80.0% | ₹25 Cr ▲56.3% | ₹16 Cr ▲45.5% | ₹11 Cr ▲37.5% | ₹8 Cr ▲33.3% | ₹6 Cr ▼40.0% | ₹10 Cr ▼9.1% | ₹11 Cr |
| PBT | ₹188 Cr ▲9.9% | ₹171 Cr ▲31.5% | ₹130 Cr ▲41.3% | ₹92 Cr ▲7.0% | ₹86 Cr ▲87.0% | ₹46 Cr ▲21.1% | ₹38 Cr ▲52.0% | ₹25 Cr |
| Tax % | 25.0% ▲0.0% | 25.0% ▼7.4% | 27.0% ▲3.8% | 26.0% ▲4.0% | 25.0% ▼3.8% | 26.0% ▲0.0% | 26.0% ▲30.0% | 20.0% |
| Net Profit | ₹141 Cr ▲10.2% | ₹128 Cr ▲36.2% | ₹94 Cr ▲38.2% | ₹68 Cr ▲6.3% | ₹64 Cr ▲88.2% | ₹34 Cr ▲21.4% | ₹28 Cr ▲40.0% | ₹20 Cr |
| EPS (₹) | 24.63 ▲9.9% | 22.41 ▲35.9% | 16.49 ▲16.5% | 14.16 ▼97.3% | 532.92 ▲85.4% | 287.5 ▲23.7% | 232.42 ▲40.3% | 165.67 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||
| Equity Capital | ₹57 Cr ▲0.0% | ₹57 Cr ▲0.0% | ₹57 Cr ▲0.0% | ₹57 Cr ▲18.8% | ₹48 Cr ▲300.0% | ₹12 Cr ▲0.0% | ₹12 Cr ▲0.0% | ₹12 Cr ▲0.0% | ₹12 Cr |
| Reserves | ₹1.0K Cr ▲7.3% | ₹964 Cr ▲6.9% | ₹902 Cr ▲16.5% | ₹774 Cr ▲238.0% | ₹229 Cr ▲16.2% | ₹197 Cr ▲48.1% | ₹133 Cr ▲35.7% | ₹98 Cr ▲40.0% | ₹70 Cr |
| Borrowings | ₹344 Cr ▲2.4% | ₹336 Cr ▼0.6% | ₹338 Cr ▲38.0% | ₹245 Cr ▲3.4% | ₹237 Cr ▲19.1% | ₹199 Cr ▲332.6% | ₹46 Cr ▼14.8% | ₹54 Cr ▼25.0% | ₹72 Cr |
| Other Liabilities | ₹403 Cr ▲20.3% | ₹335 Cr ▲23.6% | ₹271 Cr ▲12.9% | ₹240 Cr ▲25.7% | ₹191 Cr ▲14.4% | ₹167 Cr ▼6.7% | ₹179 Cr ▲121.0% | ₹81 Cr ▲19.1% | ₹68 Cr |
| Total Liabilities | ₹1.8K Cr ▲8.6% | ₹1.7K Cr ▲7.9% | ₹1.6K Cr ▲19.1% | ₹1.3K Cr ▲86.9% | ₹704 Cr ▲22.4% | ₹575 Cr ▲55.4% | ₹370 Cr ▲51.0% | ₹245 Cr ▲9.9% | ₹223 Cr |
| Assets | |||||||||
| Fixed Assets | ₹842 Cr ▼0.6% | ₹847 Cr ▲2.0% | ₹830 Cr ▲131.8% | ₹358 Cr ▲95.6% | ₹183 Cr ▲0.0% | ₹183 Cr ▲131.6% | ₹79 Cr ▲8.2% | ₹73 Cr ▼6.4% | ₹78 Cr |
| CWIP | ₹16 Cr ▲128.6% | ₹7 Cr ▼69.6% | ₹23 Cr ▼93.3% | ₹341 Cr ▲1450.0% | ₹22 Cr | ₹0 Cr ▼100.0% | ₹7 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹41 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹939 Cr ▲12.1% | ₹838 Cr ▲17.0% | ₹716 Cr ▲16.0% | ₹617 Cr ▲23.4% | ₹500 Cr ▲27.6% | ₹392 Cr ▲38.5% | ₹283 Cr ▲64.5% | ₹172 Cr ▲19.4% | ₹144 Cr |
| Total Assets | ₹1.8K Cr ▲8.6% | ₹1.7K Cr ▲7.9% | ₹1.6K Cr ▲19.1% | ₹1.3K Cr ▲86.9% | ₹704 Cr ▲22.4% | ₹575 Cr ▲55.4% | ₹370 Cr ▲51.0% | ₹245 Cr ▲9.9% | ₹223 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹117 Cr ▲82.8% | ₹64 Cr ▼56.2% | ₹146 Cr ▲117.9% | ₹67 Cr ▲13.6% | ₹59 Cr ▲40.5% | ₹42 Cr ▲35.5% | ₹31 Cr ▲63.2% | ₹19 Cr |
| Investing CF | ₹-107 Cr ▲29.6% | ₹-152 Cr ▲69.5% | ₹-499 Cr ▼448.4% | ₹-91 Cr ▲51.6% | ₹-188 Cr ▼840.0% | ₹-20 Cr ▼233.3% | ₹-6 Cr ▲33.3% | ₹-9 Cr |
| Financing CF | ₹-22 Cr ▼123.9% | ₹92 Cr ▼74.5% | ₹361 Cr ▲1237.0% | ₹27 Cr ▼78.4% | ₹125 Cr ▲757.9% | ₹-19 Cr ▲17.4% | ₹-23 Cr ▼155.6% | ₹-9 Cr |
| Net Cash Flow | ₹-12 Cr ▼400.0% | ₹4 Cr ▼50.0% | ₹8 Cr ▲166.7% | ₹3 Cr ▲160.0% | ₹-5 Cr ▼266.7% | ₹3 Cr ▲200.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Free Cash Flow | ₹55 Cr ▲150.9% | ₹-108 Cr ▲23.4% | ₹-141 Cr ▼1181.8% | ₹-11 Cr ▲47.6% | ₹-21 Cr ▼191.3% | ₹23 Cr ▼14.8% | ₹27 Cr ▲145.5% | ₹11 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 98d ▲1.0% | 97d ▲0.0% | 97d ▼6.7% | 104d ▲7.2% | 97d ▼21.1% | 123d ▲44.7% | 85d ▼8.6% | 93d |
| Inventory Days | 98d ▼17.6% | 119d ▲30.8% | 91d ▲18.2% | 77d ▲1.3% | 76d ▼29.0% | 107d ▲27.4% | 84d ▲68.0% | 50d |
| Days Payable | 110d ▼4.3% | 115d ▲1.8% | 113d ▲7.6% | 105d ▲22.1% | 86d ▼34.8% | 132d ▲43.5% | 92d ▲15.0% | 80d |
| Cash Conv. Cycle | 86d ▼14.9% | 101d ▲34.7% | 75d ▼2.6% | 77d ▼11.5% | 87d ▼12.1% | 99d ▲28.6% | 77d ▲20.3% | 64d |
| Working Capital Days | 95d ▲17.3% | 81d ▲5.2% | 77d ▲32.8% | 58d ▲56.8% | 37d ▼5.1% | 39d ▼13.3% | 45d ▲50.0% | 30d |
| ROCE | 15.0% ▲0.0% | 15.0% ▼21.1% | 19.0% ▼20.8% | 24.0% ▼22.6% | 31.0% ▲10.7% | 28.0% ▲7.7% | 26.0% | — |
Source: Screener.in · Lower days = better efficiency
About Innova Captab Limited
Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Innova Captab Limited share price today?▾
Innova Captab Limited (INNOVACAP) is currently trading at ₹867.5 on NSE, down 0.58% as of the last market session. Prices update daily after market close on MarketNetra.
Is Innova Captab Limited available in F&O (Futures & Options)?▾
Yes, Innova Captab Limited (INNOVACAP) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Innova Captab Limited 52-week high and low?▾
Innova Captab Limited's 52-week high is ₹1,021 and the 52-week low is ₹608. The current price of ₹867.5 is 15.0% below the 52W high.
What is Innova Captab Limited P/E ratio?▾
Innova Captab Limited's current P/E ratio is 35. This indicates the market is paying ₹35 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Innova Captab Limited options?▾
Innova Captab Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade INNOVACAP options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.